Search Ontology:
ChEBI

dinaciclib

Term ID
CHEBI:95060
Synonyms
  • (2S)-1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol
  • 2-[(2S)-1-(3-ethyl-7-{[(1-oxidopyridin-3-yl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)piperidin-2-yl]ethanol
  • 2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol
  • dinaciclib
  • dinaciclibum
  • MK 7965
  • MK-7965
  • MK7965
  • SCH 727965
  • SCH-727965
  • SCH727965
Definition
A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine substituted by ethyl, (2S)-2-(2-hydroxyethyl)piperidin-1-yl, and [(1-oxidopyridin-3-yl)methyl]amino groups at positions 3, 5, and 7, respectively. It is a potent pan-cyclin dependent kinase inhibitor that exhibits antineoplastic activity.
References
  • cas:779353-01-4
  • drugbank:DB12021
  • kegg.drug:D09604
  • lincs.smallmolecule:LSM-6306
  • pdb-ccd:1QK
  • pubmed:20663931
  • pubmed:21490307
  • pubmed:22315240
  • pubmed:23949430
  • pubmed:24007471
  • pubmed:24388167
  • pubmed:24393852
  • pubmed:24568369
  • pubmed:24900195
  • pubmed:25947565
  • pubmed:26018905
  • pubmed:27496135
  • pubmed:30472117
  • pubmed:31207099
  • pubmed:32269732
  • pubmed:32944844
  • pubmed:34972202
  • pubmed:35170591
  • pubmed:35884614
  • pubmed:36505806
  • pubmed:36586018
  • pubmed:36700399
  • pubmed:36979907
  • pubmed:37104883
  • pubmed:37270540
  • pubmed:37694833
  • pubmed:37703185
  • pubmed:37704591
  • pubmed:38135130
  • pubmed:38254859
  • pubmed:38438856
  • pubmed:38474332
  • pubmed:38480681
  • pubmed:38545471
  • pubmed:38685605
  • pubmed:38786326
  • pubmed:38845263
  • wikipedia.en:Dinaciclib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from dinaciclib
Phenotype where environments contain dinaciclib
Phenotype modified by environments containing dinaciclib
Phenotype affecting dinaciclib
Human Disease Model